Social Media Can Inform Patient-Doctor Dialogue About LVADs

This article originally appeared here.
Share this content:
Social Media Can Inform Patient-Doctor Dialogue About LVADs
Social Media Can Inform Patient-Doctor Dialogue About LVADs

FRIDAY, July 31, 2015 (HealthDay News) -- Social media outlets represent a promising source of information relating to left ventricular assist device treatment for heart failure, but their reliability is hampered by current lack of oversight into content, according to a study published online July 28 in Circulation: Cardiovascular Quality and Outcomes.

Kristin M. Kostick, Ph.D., from the Baylor College of Medicine in Houston, and colleagues conducted a mixed-method study, including content analysis of social media and principal components analysis of data sites discussing left ventricular assist device treatment. Aspects of interactivity, user-friendliness, appeal, medium, purpose, audience, and accuracy of information were explored.

The researchers found that the appeal and usability of available information was enhanced by higher levels of interactivity (e.g., posting comments), but also introduced greater potential for inaccuracy and inconsistency. Current lack of oversight into the content and quality of information represents a challenge for the reliability of social media as a source of information and social network-based support.

"We conclude that social media outlets constitute a promising source of informational and psychosocial support for patients, caregivers, and candidates, and if used in conjunction with patient-provider dialog, can contribute to informed decision-making by facilitating reflection and discussion of personal concerns, values, and informational needs," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »